More than 500 clinicians, researchers, patients and decision-makers will meet on 25-26 August for Danish Cancer Research Days 2022. Photo: DCCC.
18-08-2022
More than 500 clinicians, researchers, patients and decision-makers will meet on 25-26 August for Danish Cancer Research Days 2022. Minister of Health Magnus Heunicke opens the conference.
When Denmark's largest interdisciplinary cancer conference takes place in Kolding, it is with massive professional support. More than 500 participants, all of whom work with cancer treatment and research in the Danish healthcare system, have prioritised attending the conference. It is, among others, doctors, nurses, psychologists, dietitians and many other professional groups from the Danish hospitals and universities. In addition, there are representatives from patient associations and decision-makers from the healthcare system.
Difficult questions with great importance
The program includes a wide selection of current topics within cancer research and treatment. What the topics have in common is that they are highly relevant to the entire cancer field and, in their own way, must inspire and provide fertile ground for instructive discussions in connection with the conference.
Palliation is a subject which, in recent years, has occupied politicians, patients and their relatives as well as doctors and nurses across sectors. This year, the participants can look forward to learning more about the question of how to become better at ensuring everyone a dignified last time via better palliative treatment? Because how do you succeed with timely palliative care both in the municipality, in general practice and in hospitals. Both the central problems and some of the solutions that lie ahead will certainly be pointed out.
That patients participate in clinical research is absolutely crucial - both for many patients right now, for research and for future patients. With presenters from both England, the Netherlands and Denmark, you get all the way around the subject. Participants can thus look forward to learning more about how it can become more attractive for patients to participate and remain in clinical studies, as it is an important step on the way to ensuring that patients are offered the relevant research project.
There will also be a closer look at the possibilities and limitations that the patients and researchers experience that the classic randomised study entails - as well as discussing alternative study types.
- Right from the start, the conference has been part of an overall national effort to shorten the path from research to clinic - and to ensure a high and uniform level in research and clinical practice across the country, says Anne Bukh, chair of the steering commitee in DCCC and Group Director in Region North Jutland.
Latest knowledge from Danish cancer research
As is tradition, there is a separate focus on Danish clinical cancer research and how to create and improve future treatment through national and interdisciplinary projects. Here, the participants get the latest knowledge on everything from how prehabilitation can prevent complications after cancer surgery to home treatment of patients with blood cancer.
Here, research and quality work go hand in hand - both when it comes to improving survival and increasing the quality of life.
- In our highly specialised healthcare system, it is important to priorities collaboration across disciplines and professions. Only by thinking and working across disciplines can we ensure that the latest and best knowledge in the field comes into use throughout the patient journey - no matter where in the country the cancer patient meets the healthcare system, says Michael Borre, who in addition to the chairmanship of DMCG.dk is also a professor and senior physician at Urinary Tract Surgery at Aarhus University Hospital.
Younger researchers at their very best - and Flash Talks have arrived
In addition, Danish Cancer Research Days presents seven younger researchers who have won the "Exceptional Young Scientist Abstract" award in each of their categories. After close competition, they have been selected to present their research from the conference's main stage. Their abstract has been chosen from among 167 submitted abstracts, of which 120 will be presented in a poster session during the conference.
As something new this year, Flash Talks are also held, where 12 researchers make a short, oral presentation of their research. The 12 researchers must all present their research during the poster session, and with a Flash Talk they will also have the opportunity to talk about special aspects of their research and can subsequently invite further in-depth conversations with the other participants.